These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35222684)
1. Polymethyl Methacrylate-Based Smart Microfluidic Point-of-Care Testing of Prothrombin Time and International Normalized Ratio through Optical Detection. Abdulhay EW; Khnouf RE; Karain YM; Al Omari TK; Ebeid NM; Al Muhtaseb TH; Arunkumar N; Thilagaraj M; Ramirez-Gonzalez G Comput Math Methods Med; 2022; 2022():5975228. PubMed ID: 35222684 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor. Tripathi MM; Egawa S; Wirth AG; Tshikudi DM; Van Cott EM; Nadkarni SK Sci Rep; 2017 Aug; 7(1):9169. PubMed ID: 28835607 [TBL] [Abstract][Full Text] [Related]
3. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation. Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563 [TBL] [Abstract][Full Text] [Related]
5. Home prothrombin time monitoring: a literature analysis. Yang DT; Robetorye RS; Rodgers GM Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909 [TBL] [Abstract][Full Text] [Related]
6. Design and evaluation of a portable optical-based biosensor for testing whole blood prothrombin time. Yang CL; Huang SJ; Chou CW; Chiou YC; Lin KP; Tsai MS; Young KC Talanta; 2013 Nov; 116():704-11. PubMed ID: 24148464 [TBL] [Abstract][Full Text] [Related]
7. Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs. McBane RD; Felty CL; Hartgers ML; Chaudhry R; Beyer LK; Santrach PJ Mayo Clin Proc; 2005 Feb; 80(2):181-6. PubMed ID: 15704772 [TBL] [Abstract][Full Text] [Related]
8. Performance of a point-of-care device in determining prothrombin time in an anticoagulation clinic. Colella MP; Fiusa MM; Orsi FL; de Paula EV; Annichino-Bizzacchi JM Blood Coagul Fibrinolysis; 2012 Mar; 23(2):172-4. PubMed ID: 22246165 [TBL] [Abstract][Full Text] [Related]
9. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs. Ino N; Masutani S; Tanikawa S; Iwamoto Y; Saiki H; Ishido H; Tamura M; Senzaki H J Cardiol; 2018 Feb; 71(2):187-191. PubMed ID: 29066099 [TBL] [Abstract][Full Text] [Related]
10. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery. Okabayashi S; Ogawa S; Tanaka KA; Nishiyama T; Takeshita S; Nakayama Y; Nakajima Y; Sawa T; Mizobe T J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816 [TBL] [Abstract][Full Text] [Related]
11. Performance of a point-of-care device in determining prothrombin time in supra-therapeutic INRs. Hashimoto VA; De Paula EV; Colella MP; Luz Fiusa MM; Montalvao SA; Machado TF; Orsi FA; Annichino-Bizzacchi JM Int J Lab Hematol; 2013 Apr; 35(2):211-6. PubMed ID: 23173728 [TBL] [Abstract][Full Text] [Related]
12. Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method. Taborski U; Braun SL; Völler H J Thromb Thrombolysis; 2004 Oct; 18(2):103-7. PubMed ID: 15789176 [TBL] [Abstract][Full Text] [Related]
13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Jonsson M; Hillarp A; Svensson P Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors. Spinler SA; Nutescu EA; Smythe MA; Wittkowsky AK Ann Pharmacother; 2005 Jun; 39(6):1049-55. PubMed ID: 15855245 [TBL] [Abstract][Full Text] [Related]
15. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Kong MC; Lim TG; Ng HJ; Chan YH; Lee LH Ann Hematol; 2008 Nov; 87(11):905-10. PubMed ID: 18604535 [TBL] [Abstract][Full Text] [Related]
16. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin. Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152 [TBL] [Abstract][Full Text] [Related]
17. Results of the performance verification of the CoaguChek XS system. Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761 [TBL] [Abstract][Full Text] [Related]
18. CoaguChek® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome. Fonseca MES; Balbi GGM; Signorelli F; Gouvea CP; de Andrade DCO Lupus; 2022 Apr; 31(5):565-574. PubMed ID: 35266798 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of CoaguChek XS for measuring prothrombin time in patients receiving long-term oral anticoagulant therapy]. Lee JH; Lee KS; Kim DS; Lee HS; Choi SI; Cho YG Korean J Lab Med; 2007 Jun; 27(3):177-81. PubMed ID: 18094572 [TBL] [Abstract][Full Text] [Related]
20. Point of care monitors for oral anticoagulant therapy. Nutescu EA Semin Thromb Hemost; 2004 Dec; 30(6):697-702. PubMed ID: 15630676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]